-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2025 to Q2 2025.
- Inhibrx Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 80.6 %.
Debt-to-equity, Quarterly (%)